Skip to main content

Table 3 Associations of time- and frequency- domain heart rate variability with C-peptidogenic index, overall insulin secretion, beta cell glucose sensitivity, beta cell potentiation factor, and beta cell rate sensitivity

From: Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study

 

C-peptidogenic index

P-value

Overall insulin secretion

P-value

Beta cell glucose sensitivity

P-value

Beta cell potentiation factor

P-value

Beta cell rate sensitivity

P-value

HRV time- domain, per SD

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

Crude

-0.061 (-0.104 to -0.017)

0.007

-0.010 (-0.054 to 0.033)

0.641

-0.040 (-0.084 to 0.003)

0.070

-0.073 (-0.116 to -0.029)

0.001

-0.038 (-0.082 to 0.006)

0.088

1

-0.060 (-0.104 to -0.016)

0.008

-0.004 (-0.048 to 0.040)

0.870

-0.043 (-0.086 to 0.001)

0.058

-0.073 (-0.117 to -0.029)

0.001

-0.021 (-0.065 to 0.023)

0.340

2

-0.059 (-0.104 to -0.014)

0.010

-0.037 (-0.081 to 0.006)

0.089

-0.048 (-0.093 to -0.004)

0.033

-0.045 (-0.088 to -0.001)

0.043

-0.023 (-0.067 to 0.022)

0.315

3 A

-0.051 (-0.097 to -0.006)

0.027

-0.041 (-0.084 to 0.002)

0.060

-0.040 (-0.084 to 0.004)

0.077

-0.038 (-0.081 to 0.006)

0.089

-0.016 (-0.061 to 0.029)

0.49

3B

-0.049 (-0.094 to -0.003)

0.035

-0.037 (-0.080 to 0.006)

0.092

-0.037 (-0.082 to 0.007)

0.098

-0.038 (-0.082 to 0.006)

0.087

-0.012 (-0.057 to 0.033)

0.589

HRV frequency- domain, per SD

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

stβ [95% CI]

 

Crude

-0.061 (-0.105 to -0.018)

0.006

-0.014 (-0.058 to 0.030)

0.770

-0.044 (-0.088 to -0.0001)

0.049

-0.073 (-0.116 to -0.029)

0.001

-0.038 (-0.082 to 0.005)

0.086

1

-0.060 (-0.104 to -0.015)

0.009

-0.005 (-0.049 to 0.040)

0.833

-0.045 (-0.090 to -0.001)

0.044

-0.072 (-0.116 to -0.028)

0.001

-0.017 (-0.062 to 0.027)

0.443

2

-0.059 (-0.104 to -0.014)

0.011

-0.036 (-0.080 to 0.007)

0.100

-0.051 (-0.095 to -0.006)

0.026

-0.046 (-0.089 to -0.002)

0.041

-0.018 (-0.063 to 0.026)

0.417

3 A

-0.050 (-0.096 to -0.004)

0.033

-0.039 (-0.082 to 0.005)

0.082

-0.039 (-0.084 to 0.006)

0.087

-0.035 (-0.079 to 0.009)

0.118

-0.010 (-0.056 to 0.035)

0.652

3B

-0.048 (-0.094 to -0.002)

0.040

-0.035 (-0.078 to 0.009)

0.117

-0.036 (-0.081 to 0.008)

0.109

-0.035 (-0.078 to 0.012)

0.122

-0.008 (-0.053 to 0.037)

0.734

  1. Standardized regression coefficient (stβ) represents the difference in beta cell index (in SD) per 1-SD lower HRV measure, where time domain HRV was estimated from SDNN, SDANN, RMSSD, SDNN index and pNN50; and frequency domain was estimated from TP, ULF, VLF, LF, and HF. Overall beta cell response composite score was estimated from C-peptidogenic index, overall insulin secretion, beta cell glucose sensitivity, beta cell potentiation factor, and beta cell rate sensitivity
  2. Bold indicates p < 0.05
  3. Variables entered in the models in addition to HRV: Crude: none; model 1: age, sex, and educational status (low, medium, high); model 2: model 1 + Matsuda Index; model 3 A: model 2 + total cholesterol/HDL cholesterol ratio, lipid-modifying medication (yes/no), BMI, smoking status (current, ever, never), and alcohol consumption status (none, low, high); Model 3B: model 3 A + office systolic blood pressure and use of antihypertensive medication
  4. Abbreviations: SD, standard deviation; CI, confidence interval; HRV, heart rate variability, HDL, high density lipid; BMI, body-mass index. All abbreviations for indices of HRV are presented in the Methods section